RSS   Newsletter   Contact   Advertise with us
Post Online Media

Conatus CFO Charles J. Cashion to resign

ConatusConatus Pharmaceuticals Inc., a biotechnology company, announced that Charles J. Cashion tendered his resignation as senior vice president, finance, chief financial officer and secretary.
Mr. Cashion is one of company's co-founders and has served as Senior Vice President, Finance, Chief Financial Officer, and Secretary since July 2005.

From 2001 to 2005, Mr. Cashion was Chief Financial Officer at Idun Pharmaceuticals, Inc., a privately-owned biopharmaceutical company.

Mr. Cashion has held several senior level management positions in both private and public healthcare companies with responsibilities for securing and executing various types of financings including initial public offerings, secondary offerings, corporate partnerships, and debt.

Mr. Cashion joined Idun Pharmaceuticals in 2001 as Executive Vice President, Chief Financial Officer and Secretary.

Previously, he held the position of Senior Vice President and Chief Financial Officer of Quidel Corporation, a publicly-held medical diagnostics company.

For the prior nine years, Mr. Cashion was Senior Vice President, Finance, and Chief Financial Officer of The Immune Response Corporation, a publicly-held biopharmaceutical company.

During the period from 1980 to 1989, he was Executive Vice President and Chief Financial Officer of Smith Laboratories, Inc., a publicly-held pharmaceutical company and during 1987 through 1989 was also President and Chief Executive Officer of Sutter Corporation, an orthopedic products subsidiary of Smith Laboratories.

Mr. Cashion also held positions at Baxter International, Inc. and Motorola, Inc.

Mr. Cashion holds an M.B.A. and B.S. in Accounting from Northern Illinois University.




We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy